Table 1. Medicines evaluated in the present study.
| Medicine | Number of publications |
|---|---|
| Donepezil | 7 |
| Galantamine | 5 |
| Rivastigmine | 3 |
| Pioglitazone | 2 |
| Doxycycline | 2 |
| Rifampicin | 2 |
| Resveratrol | 2 |
| Metrifonate | 2 |
| Acetyl-L-carnitine (ALCAR) | 1 |
| Saffron | 1 |
| Tulrampator (S47445) | 1 |
| Fisostigmine | 1 |
| Cerebrolysin | 1 |
| Tacrine | 1 |
| Eptastigmine | 1 |
| Diclofenac | 1 |
| Misoprostol | 1 |
| PF-05212377 (SAM-760) | 1 |
| Scyllo-Inositol (ELND005) | 1 |
| Semagacestat | 1 |
| Huperzine A | 1 |
| Tideglusibe | 1 |
| Sodium selenate | 1 |
| Capric/Caprylic Acid Triglycerides | 1 |
| Vitamin D2 | 1 |
| ABT-288 | 1 |
| Simvastatin | 1 |
| Atomoxetine | 1 |
| Benfotiamine | 1 |
| Docosahexaenoic acid | 1 |
| Bexarotene | 1 |
| Hydroxychloroquine | 1 |
| Levetiracetam | 1 |
| Masupirdine | 1 |
| Rotigotine | 1 |
| Tarenflurbil | 1 |
| NeuroAiD™ (MLC601) | 1 |
| Octohydroaminoacridine | 1 |
| Velnacrine | 1 |
| EHT0202 (Etazolate hydrochloride) | 1 |
| Vitamin B | 1 |
| MK-7622 | 1 |
| Edonerpic maleate (T-817MA) | 1 |
| Idalopirdine | 1 |
| UB-311 | 1 |
| SB-742457 | 1 |
| Omega-3 | 1 |
| Tramiprosate | 1 |
| Velnacrine | 1 |
| Blarcamesine | 1 |
| Alphoscerate | 1 |
| Posiphen | 1 |